Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$152.21 USD

152.21
1,200,439

-4.39 (-2.80%)

Updated Aug 7, 2025 01:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (69 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Here's Why You Should Buy Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, the cost of products continues to rise.

Zacks Equity Research

AngioDynamics (ANGO) Q2 Earnings, Revenues Top Estimates

by Zacks Equity Research

AngioDynamics (ANGO) registers strong revenue growth in the Med Tech and Med Device businesses in second-quarter fiscal 2023.

Tirthankar Chakraborty headshot

5 Top Recession-Proof Dividend Stocks to Buy in 2023

by Tirthankar Chakraborty

Investors should place their bets now on dividend-paying recession-proof stocks such as Cardinal Health (CAH), Conagra Brands (CAG), Ingredion (INGR), Atmos Energy (ATO) and NRG Energy (NRG) for a steady income.

Zacks Equity Research

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Zacks Equity Research

Here's Why You Should Retain Stryker (SYK) Stock for Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on it.

Zacks Equity Research

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Zacks Equity Research

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

Sweta Killa headshot

5 Stocks in S&P 500 ETF With 40% Gains in 2022

by Sweta Killa

The S&P 500 wrapped up its worst year since 2008, tumbling 20%. Persistently high inflation, a hawkish Fed, Russia's invasion of Ukraine and a resurgence of COVID-19 cases in China weighed heavily on investor sentiment.

Zacks Equity Research

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Equity Research

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DEF

Zacks Equity Research

Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DEF

Zacks Equity Research

Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year?

by Zacks Equity Research

Here is how Acer Therapeutics Inc. (ACER) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks Equity Research

Zacks.com featured highlights include Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block

by Zacks Equity Research

Archer-Daniels-Midland, Cardinal Health, Insperity, Deere & Co. and H&R Block are part of the Zacks Screen of the Week.

Zacks Equity Research

What Makes Cardinal Health (CAH) a Strong Momentum Stock: Buy Now?

by Zacks Equity Research

Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Indrajit Bandyopadhyay headshot

5 Winning Medical Product Stocks That Still Have Room to Run

by Indrajit Bandyopadhyay

Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain from strong fundamentals.

Sweta Killa headshot

5 Top-Ranked Dividend Growth Stocks for 2023

by Sweta Killa

Archer-Daniels-Midland (ADM), Cardinal Health (CAH), Insperity (NSP), Deere & Company (DE), and H&R Block (HRB) could be compelling picks for 2023.

Maharathi Basu headshot

5 Broker-Friendly Stocks to Bank On as Volatility Persists

by Maharathi Basu

Broker-favorite stocks like Cardinal Health (CAH), American Airlines (AAL), Boise Cascade (BCC), AmerisourceBergen (ABC) and Centene (CNC) should be on an investors' watchlist.

Zacks Equity Research

Should Invesco S&P Ultra Dividend Revenue ETF (RDIV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for RDIV

Zacks Equity Research

Is Cardinal Health (CAH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Derek Lewis headshot

3 Top S&P 500 Performers of 2022

by Derek Lewis

Investors are more than aware of how harsh the market has been in 2022, with many stocks residing in the red year-to-date. Still, these three stocks have snapped the bearish trend, delivering substantial gains to shareholders.

Zacks Equity Research

3 Reasons Why Cardinal (CAH) Is a Great Growth Stock

by Zacks Equity Research

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Indrajit Bandyopadhyay headshot

3 Medical Stocks Creating Wealth Despite Macro Challenges

by Indrajit Bandyopadhyay

Here we discuss three stocks - CAH, LNTH and TMDX - that have been creating wealth for their investors in 2022 as several competitors faltered amid macro challenges. Will the trend continue?

Zacks Equity Research

Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SPYD

Zacks Equity Research

The Zacks Analyst Blog Highlights Enphase Energy, Halliburton, Cardinal Health and W.R. Berkley

by Zacks Equity Research

Enphase Energy, Halliburton, Cardinal Health and W.R. Berkley are included in this Analyst Blog.

Zacks Equity Research

Why Is Dentsply (XRAY) Up 1% Since Last Earnings Report?

by Zacks Equity Research

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.